Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits

Atherosclerosis

Volumn 189, Issue 2, 2006, Pages 358-363

  Pfister, Sandra L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Contractions; Endothelium; Hypercholesterolemia; Thromboxane

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; CHOLESTEROL; PHENYLEPHRINE; THROMBOXANE A2; THROMBOXANE RECEPTOR; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA DISEASE; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DISEASE COURSE; EVALUATION; FATTY ACID SYNTHESIS; FEEDING; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RABBIT; RECEPTOR DOWN REGULATION; THROMBOCYTE; TIME; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPERCHOLESTEROLEMIA; MALE; RABBITS; RECEPTORS, THROMBOXANE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 33750292018     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.004     Document Type: Article

References (30)

1. Tunstall-Pedoe H., and Smith W.C.S. Cholesterol as a risk factor for coronary heart disease. Br Med J 46 (1990) 1075-1087
2. Inkeles S., and Eisenberg D. Hyperlipidemia and coronary atherosclerosis: a review. Med Baltimore 60 (1981) 110-123
3. Heistad D.D., Armstrong M.L., Marcus M.L., Piegors D.J., and Mark A.L. Potentiation of vasoconstrictor responses to serotonin in the limb of athersclerotic monkeys. J Hypertens 4 1 (1986) S17-S21
4. Bloom D., McCalden T.A., and Rosendorff C. The effects of hypercholesterolemic plasma on vascular sensitivity to noradrenaline. Br J Pharmacol 54 (1975) 421-427
5. Yokoyama M., and Henry P.D. Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res 45 (1975) 479-486
6. Harrison D.G., Freiman P.C., Armstrong M.L., Marcus M.L., and Heistad D.D. Alterations of vascular reactivity in atherosclerosis. Circ Res 61 Suppl II (1987) 74-80
7. Mehta J.L., Lawson D., Mehta P., and Saldeen T. Increased prostacylcin and thromboxane A2 biosynthesis in atherosclerosis. Proc Natl Acad Sci USA 85 (1988) 4511-4515
8. Gryglewski R.J., Dembinska-Kiec A., Zmuda A., and Gryglewski J. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 31 (1978) 385
9. Wang T., Falardeau P., and Powell W. Synthesis of prostaglandins and thromboxane B2 by cholesterol-fed rabbits. Arterioscler Thromb 11 (1991) 501-508
10. Osborne J.A., and Lefer A.M. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits. Am J Physiol 255 (1988) H318-H324
11. Kobayashi T., Tahara Y., Matsumoto M., et al. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114 (2004) 784-794
12. Cayatte A., Du Y., Oliver-Krasinski J., Lavielle G., Verbeuren T., and Cohen R. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 20 (2000) 1724-1728
13. Thomas D., Mannon R., Mannon P., et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102 (1998) 1994-2001
14. Buzzard C.J., Pfister S.L., Halushka P.V., and Campbell W.B. Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic. Am J Physiol 266 (1994) H2320-H2326
15. Pfister S.L., Kotulock D.A., and Campbell W.B. Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits. Hypertension 29 [part 2] (1997) 303-309
16. Pfister S.L. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 43 (2004) 428-433
17. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M., and Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58 (1986) 552-564
18. Galle J., Busse R., and Bassenge E. Hypercholesterolemia and atherosclerosis change vascular reactivity in rabbits by different mechanisms. Arterioscl Thromb 11 (1991) 1712-1718
19. Merkel L.A., Rivera L.M., Bilder G.E., and Perrone M.H. Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol. Circ Res 67 (1990) 550-555
20. Jayakody L., Senaratne M., Thomson A., and Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 60 (1987) 251-264
21. Asada Y., Yamamoto R., Takasaki K., and Sumiyoshi A. Vascular contraction in perfused carotid arteries of cholesterol-fed rabbits. Atherosclerosis 94 (1992) 233-239
22. Cooke J.P., Andon N.A., Girerd X.A., Hirsch A.T., and Creager M.A. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 83 (1991) 1057-1062
23. Fujiwara T., and Chiba S. Alterations of vascular alpha 1-adrenergic contractile responses in hypercholesterolemic rabbit common carotid arteries. J Cardiovasc Pharmacol 22 (1993) 58-64
24. Fontes Ribeiro C.A., Almeida L., Paiva I., et al. Influence of 0.1 or 0.2% cholesterol-enriched diets on the induction of atherosclerosis and aorta reactivity in vitro. J Cardiovasc Pharmacol 31 (1998) 690-699
25. Pfister S.L., and Campbell W.B. Contribution of arachidonic acid metabolites to reduced norepinephrine-induced contractions in hypercholesterolemic rabbit aortas. J Cardiovasc Pharmacol 28 (1996) 784-791
26. Ishizuka T., Matsui T., and Kurita A. Ramatroban a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbits in vivo. Eur J Pharmacol 468 (2003) 27-35
27. Yamada T., Fujino T., Yuhki K., et al. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase. Circulation 108 (2003) 2381-2386
28. Buetler T., Krauskopf A., and Ruegg U. Role of superoxide as a signaling molecule. News Physiol Sci 19 (2004) 120-123
29. Muzaffar S., Shukla N., Lobo C., Angelini G., and Jeremy J. Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br J Pharmacol 141 (2004) 488-496
30. Huang J.S., Ramamurthy S.K., Lin X., and Le Breton G.C. Cell signalling through thromboxane A2 receptors. Cell Signal 16 (2004) 521-533